Lipid nanoparticles boost potential vaccine against SARS-CoV-2

Published October 28, 2020


Advanced Science News ran a story about a research team led by biomedical engineer Jonathan Lovell that has discovered a technique that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes COVID-19.

“We induce RBD [receptor binding domain] to spontaneously self-assemble into particles. In particle format, the RBD is better recognized by the immune system, and leads to better generation of antibodies that neutralize the virus,” says Lovell, an associate professor in the Department of Biomedical Engineering.

Read the story here.